InvestorsHub Logo
Followers 117
Posts 20162
Boards Moderated 0
Alias Born 06/13/2011

Re: Glider549 post# 106

Monday, 12/16/2019 1:45:41 PM

Monday, December 16, 2019 1:45:41 PM

Post# of 1469
Gilder ..the issue is the following

. As anticipated due to the mechanism of action, the most common self-reported adverse event was loose stools/diarrhea at an incidence rate of 52.5%, with approximately 90% of these events judged by the investigator to be mild to moderate in nature.


My wife is a PA in dialysis clinics. These patients need to stay hooked up to the dialysis machine 4 hrs a day ...3 times a week ......so loose stool / diarrhea is a problem they ( running the clinic ) don't want to deal with .

This drug is a real winner IF they can find a way to reduce rate of diarrhea/ loose stool .
If they announce anything regarding this ..please post
JMO
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARDX News